We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!
0
Signin
countryflagUS

18889881171

MSFT 417.83 -0.6798% AAPL 226.85 0.2829% NVDA 118.714 1.465% GOOGL 165.686 -0.7809% GOOG 167.125 -0.7689% AMZN 185.38 0.135% META 573.28 -0.5534% AVGO 171.45 2.3765% TSLA 249.36 -3.3563% TSM 175.7 2.1096% LLY 890.255 0.6529% V 276.22 -0.4971% JPM 207.51 0.227% UNH 592.97 1.6578% NVO 116.255 -1.4872% WMT 80.19 -1.3289% LVMUY 147.83 0.2441% XOM 120.8281 0.7489% LVMHF 740.0 0.955% MA 495.19 -0.2397%

OPTIMIZERx Corp

Healthcare US OPRX

7.24USD
0.04(0.56%)

Last update at 2024-10-02T18:55:00Z

Day Range

6.847.22
LowHigh

52 Week Range

6.9216.64
LowHigh

Fundamentals

  • Previous Close 7.20
  • Market Cap231.30M
  • Volume178148
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-8.23219M
  • Revenue TTM78.21M
  • Revenue Per Share TTM4.50
  • Gross Profit TTM 38.97M
  • Diluted EPS TTM-1.04

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.43844M 0.38M -2.20713M -4.04054M 0.23M
Minority interest - - - - -
Net income -10.58614M 0.27M -2.38374M -3.14258M 0.23M
Selling general administrative 49.24M 33.19M 24.16M 17.85M 11.71M
Selling and marketing expenses - 1.03M 0.62M 0.71M 0.30M
Gross profit 38.97M 35.64M 24.11M 15.44M 12.21M
Reconciled depreciation 2.02M 1.97M 1.97M 1.18M 0.32M
Ebit -12.29074M 0.48M -1.89012M -3.69356M 0.18M
Ebitda -10.26871M 2.45M 0.08M -1.77578M 0.50M
Depreciation and amortization 2.02M 1.97M 1.97M 1.92M 0.32M
Non operating income net other 0.02M 0.02M -0.07181M -0.34697M 0.05M
Operating income -12.29074M 0.48M -1.89012M -3.69356M 0.18M
Other operating expenses 74.74M 60.93M 45.45M 28.29M 21.03M
Interest expense 0.85M 0.12M 0.07M 0.98M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M -0.89796M 0.00000M
Interest income 0.85M 0.02M 0.07M 0.29M 0.05M
Net interest income 0.85M 0.02M 0.07M 0.29M 0.05M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.85230M 0.10M 0.18M -0.89796M 0.05M
Total revenue 62.45M 61.29M 43.31M 24.60M 21.21M
Total operating expenses 51.26M 35.28M 26.24M 19.13M 12.03M
Cost of revenue 23.48M 25.65M 19.21M 9.16M 9.00M
Total other income expense net 0.85M -0.10415M -0.31700M -0.34697M -0.60767M
Discontinued operations - - - - -
Net income from continuing ops 0.38M 0.38M -2.20713M -3.14258M 0.23M
Net income applicable to common shares 0.38M 0.38M -2.20713M -3.14258M 0.23M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 183.37M 134.65M 140.99M 60.33M 56.64M
Intangible assets 49.40M 13.02M 10.65M 12.12M 13.94M
Earning assets - - - - -
Other current assets 3.19M 0.47M 5630655.00M 4.46M 0.87M
Total liab 56.82M 8.54M 9.61M 10.35M 11.78M
Total stockholder equity 126.55M 126.11M 131.38M 49.97M 44.86M
Deferred long term liab - - - - -
Other current liab 13.26M 2.60M 2.90M 4.03M 3.30M
Common stock 0.02M 0.02M 0.02M 0.02M 0.01M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.01M
Retained earnings -64.25796M -46.69210M -35.25366M -35.63174M -33.42461M
Other liab - - - - 5.22M
Good will 78.36M 22.67M 14.74M 14.74M 14.74M
Other assets 0.00000M 0.00505M 0.01M 0.01M 0.08M
Cash 13.85M 18.21M 84.68M 10.52M 18.85M
Cash and equivalents - - - - -
Total current liabilities 17.88M 8.40M 9.37M 10.03M 6.11M
Current deferred revenue 0.17M 0.16M 1.39M 0.29M 0.58M
Net debt 22.97M -17.97425M -84.35406M -10.06802M -18.28850M
Short term debt 2.22M 0.09M 0.09M 0.12M 0.12M
Short long term debt 2.00M - - - -
Short long term debt total 36.82M 0.23M 0.33M 0.45M 0.56M
Other stockholder equity 190.79M 172.78M 166.62M 85.59M 78.27M
Property plant equipment - 0.14M 0.47M 0.15M 0.74M
Total current assets 54.33M 98.58M 115.11M 32.86M 27.14M
Long term investments - - - - -
Net tangible assets - 131.38M 105.99M 49.97M 16.18M
Short term investments 0.00000M 55.93M - - -
Net receivables 37.29M 22.16M 24.80M 17.89M 7.42M
Long term debt 34.23M - - - -
Inventory - 1.81M -5630649.36935M - -
Accounts payable 2.23M 5.54M 4.99M 5.59M 2.11M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -0.14892M
Additional paid in capital - - - - -
Common stock total equity - 0.02M 0.02M 0.02M 0.01M
Preferred stock total equity - - - - -
Retained earnings total equity - -35.25366M -35.25366M -35.63174M -33.42461M
Treasury stock - -0.00121M - - -
Accumulated amortization - - - - -
Non currrent assets other 0.57M 0.00505M 0.01M 0.01M 0.08M
Deferred long term asset charges - - - - -
Non current assets total 129.04M 36.07M 25.87M 27.47M 29.50M
Capital lease obligations 0.59M 0.23M 0.33M 0.45M 0.56M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -55.93182M -0.48600M -0.12473M -10.58209M -5.68683M
Change to liabilities 1.45M 1.09M 1.14M -0.61550M 0.10M
Total cashflows from investing activities -0.48600M -0.48600M -0.12473M -10.58209M -5.68683M
Net borrowings - - - - -
Total cash from financing activities -18.95078M 73.92M -1.90079M 22.18M 8.69M
Change to operating activities 1.96M -1.40824M 1.14M -1.17266M 0.64M
Net income -11.43844M 0.38M -2.20713M -3.14258M 0.23M
Change in cash -66.47308M 74.16M -8.33590M 9.94M 3.79M
Begin period cash flow 84.68M 10.52M 18.85M 8.91M 5.12M
End period cash flow 18.21M 84.68M 10.52M 18.85M 8.91M
Total cash from operating activities 10.65M 0.73M -6.31039M -1.66080M 0.79M
Issuance of capital stock 0.00000M 70.67M 0.00000M 21.30M 8.16M
Depreciation 2.02M 1.97M 1.97M 1.28M 0.32M
Other cashflows from investing activities -0.38568M -0.38568M -0.05668M -10.49437M -5.65247M
Dividends paid - - - - -
Change to inventory - -0.81659M -2.20716M -0.88248M -0.09322M
Change to account receivables 2.28M -6.99488M -10.66768M -0.54883M -2.78925M
Sale purchase of stock -20.02426M 75.54M 2.49M 22.18M 8.69M
Other cashflows from financing activities -70670.46252M 3.25M -1.90079M 0.88M 0.52M
Change to netincome 0.12M 5.69M 3.62M 2.18M 1.87M
Capital expenditures 0.24M 0.49M 0.12M 1.59M 0.09M
Change receivables -6.99488M -6.99488M -10.66768M -0.62883M -2.78925M
Cash flows other operating 5.77M 5.77M 1.80M -0.63402M 1.07M
Exchange rate changes - - - - -
Cash and cash equivalents changes 74.16M 74.16M -8.33590M 9.94M 3.79M
Change in working capital 3.96M -7.31045M -9.69238M -1.79835M -2.27354M
Stock based compensation 15.75M 5.49M 3.17M 2.26M 1.86M
Other non cash items 0.36M 0.12M 0.25M 0.64M 0.66M
Free cash flow 10.41M 0.24M -6.43511M -3.24851M 0.70M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OPRX
OPTIMIZERx Corp		 0.04 0.56% 7.24 - 30.77 3.11 1.68 2.10 -9.0916
GEHC
GE HealthCare Technologies Inc.		 -0.16 0.17% 91.51 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -0.42 0.20% 207.20 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 10.20 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 - -% 5.11 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

OPTIMIZERx Corp

400 Water Street, Rochester, MI, United States, 48307

Key Executives

Name Title Year Born
Mr. William J. Febbo CEO & Director 1969
Mr. Edward Stelmakh C.M.A., M.B.A., MBA CFO & COO 1966
Ms. Marion K Odence-Ford Gen. Counsel & Chief Compliance Officer 1965
Mr. Douglas P. Baker Exec. VP of Fin. & Accounting 1957
Mr. Andrew Jacob D'Silva Sr. VP of Corp. Fin. NA
Mr. Todd Inman Chief Technology Officer 1955
Maira Alejandra Media Relations Mang. NA
Ms. Sheryl Kearney HR Mang. NA
Mr. Terence J. Hamilton Sr. VP of Pharma 1965
Mr. Stephen L. Silvestro Chief Commercial Officer 1978

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.